• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Paysign to Host First Quarter 2025 Earnings Call

    4/22/25 4:30:00 PM ET
    $PAYS
    Business Services
    Consumer Discretionary
    Get the next $PAYS alert in real time by email

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss first quarter 2025 earnings at 5:00 p.m. ET on Thursday, May 8, 2025.

    Participant details are as follows:

    U.S. dial-in: 800.579.2543

    International dial-in: +1.785.424.1789

    Conference ID: PAYSIGN

    Webcast: Click Here

    Replay:

    Dial-in: 877.660.6853 or +1.201.612.7415

    Conference ID: 13753463

    The replay will be available until August 8, 2025.

    To register as a financial professional in order to ask questions during the call, please email [email protected] no later than 5:00 p.m. ET on Friday, May 2, 2025.

    About Paysign

    Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit paysign.com.

    Forward-Looking Statements

    Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250422454183/en/

    Investor Relations

    [email protected]

    888.522.4853

    paysign.com/investors

    Media Relations

    Alicia Ches

    888.522.4850

    [email protected]

    Get the next $PAYS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PAYS

    DatePrice TargetRatingAnalyst
    12/20/2024$6.00Buy
    Lake Street
    3/30/2022$4.00Mkt Perform
    Barrington Research
    3/24/2022Buy → Neutral
    Ladenburg Thalmann
    8/20/2021$3.50Neutral → Buy
    DA Davidson
    8/19/2021Neutral → Buy
    DA Davidson
    8/12/2021$3.50 → $3.75Neutral → Buy
    Ladenburg Thalmann
    More analyst ratings

    $PAYS
    Leadership Updates

    Live Leadership Updates

    See more
    • Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

      Paysign Strengthens Leadership in Technology for Plasma and Pharmaceutical Industries  Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the assets of Gamma Innovation LLC (Gamma), significantly enhancing Paysign's capabilities in plasma donor and pharmaceutical patient engagement technologies. As part of this strategic acquisition, Paysign has appointed Michael Ngo, former Managing Member of Gamma, as its Chief Innovation Officer. "This acquisition represents an exciting milestone for Paysign as we accelerate our growth strategy and expand our

      3/25/25 8:05:00 AM ET
      $PAYS
      Business Services
      Consumer Discretionary

    $PAYS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Henry Daniel R bought $67,716 worth of shares (19,800 units at $3.42), increasing direct ownership by 25% to 99,800 units (SEC Form 4)

      4 - Paysign, Inc. (0001496443) (Issuer)

      5/28/25 8:07:31 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Mina Bruce A bought $5,801 worth of shares (1,206 units at $4.81), increasing direct ownership by 0.56% to 218,500 units (SEC Form 4)

      4 - Paysign, Inc. (0001496443) (Issuer)

      5/15/24 6:19:59 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Topline Capital Management, Llc bought $333,465 worth of shares (112,725 units at $2.96) (SEC Form 4)

      4 - Paysign, Inc. (0001496443) (Issuer)

      3/18/24 8:57:59 PM ET
      $PAYS
      Business Services
      Consumer Discretionary

    $PAYS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Paysign, Inc. to Present at the MicroCap Rodeo Spring Conference

      Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced its CFO, Jeff Baker, will be attending and presenting at the MicroCap Rodeo Spring Conference in New York City on Wednesday, June 4, 2025. The presentation will be at 3:00 p.m. Eastern time on Wednesday, June 4, and will be webcast live. Interested parties can register to watch the virtual presentation. Management will also be available for one-on-one meetings with approved investors. Investors interested in attending may visit the event website for more information and to pre-register. Abo

      5/29/25 4:30:00 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Paysign, Inc. Reports First Quarter 2025 Financial Results

      First quarter 2025 total revenues of $18.60 million, up 41.0% from first quarter 2024 First quarter 2025 net income of $2.59 million, or diluted earnings per share of $0.05, versus net income of $309 thousand, or diluted earnings per share of $0.01, for first quarter 2024 First quarter 2025 Adjusted EBITDA of $4.96 million, up 193.3% from $1.69 million a year ago, while diluted Adjusted EBITDA per share was $0.09 versus $0.03 for first quarter 20241 Total plasma center count increased by four net centers during first quarter 2025, exiting the quarter with 484 centers; revenue per plasma center decreased to $6,517 compared to $7,414 for the same period last year; year-over-year plasma

      5/8/25 4:05:00 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Paysign to Host First Quarter 2025 Earnings Call

      Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss first quarter 2025 earnings at 5:00 p.m. ET on Thursday, May 8, 2025. Participant details are as follows: U.S. dial-in: 800.579.2543 International dial-in: +1.785.424.1789 Conference ID: PAYSIGN Webcast: Click Here Replay: Dial-in: 877.660.6853 or +1.201.612.7415 Conference ID: 13753463 The replay will be available until August 8, 2025. To register as a financial professional in order to ask questions during the call, please email [email protected] no later than 5:00 p.m. ET on Friday, May 2, 2025.

      4/22/25 4:30:00 PM ET
      $PAYS
      Business Services
      Consumer Discretionary

    $PAYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on PaySign with a new price target

      Lake Street initiated coverage of PaySign with a rating of Buy and set a new price target of $6.00

      12/20/24 8:45:02 AM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Barrington Research initiated coverage on PaySign with a new price target

      Barrington Research initiated coverage of PaySign with a rating of Mkt Perform and set a new price target of $4.00

      3/30/22 8:15:53 AM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • PaySign downgraded by Ladenburg Thalmann

      Ladenburg Thalmann downgraded PaySign from Buy to Neutral

      3/24/22 7:30:30 AM ET
      $PAYS
      Business Services
      Consumer Discretionary

    $PAYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Paysign Inc.

      SC 13G/A - Paysign, Inc. (0001496443) (Subject)

      11/14/24 7:00:30 AM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

      SC 13G/A - Paysign, Inc. (0001496443) (Subject)

      2/12/24 12:36:58 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

      SC 13G/A - Paysign, Inc. (0001496443) (Subject)

      1/24/24 4:05:27 PM ET
      $PAYS
      Business Services
      Consumer Discretionary

    $PAYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Henry Daniel R bought $67,716 worth of shares (19,800 units at $3.42), increasing direct ownership by 25% to 99,800 units (SEC Form 4)

      4 - Paysign, Inc. (0001496443) (Issuer)

      5/28/25 8:07:31 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Large owner Spence Daniel disposed of 4,695,000 shares, decreasing direct ownership by 52% to 4,295,000 units (SEC Form 4)

      4 - Paysign, Inc. (0001496443) (Issuer)

      3/25/25 9:15:04 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Large owner Spence Daniel sold $375,780 worth of shares (100,000 units at $3.76), decreasing direct ownership by 1% to 8,990,000 units (SEC Form 4)

      4 - Paysign, Inc. (0001496443) (Issuer)

      3/25/25 9:00:14 PM ET
      $PAYS
      Business Services
      Consumer Discretionary

    $PAYS
    SEC Filings

    See more
    • Paysign Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Paysign, Inc. (0001496443) (Filer)

      5/12/25 9:00:07 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Paysign Inc.

      10-Q - Paysign, Inc. (0001496443) (Filer)

      5/9/25 8:28:17 AM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Paysign Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Paysign, Inc. (0001496443) (Filer)

      5/8/25 4:05:45 PM ET
      $PAYS
      Business Services
      Consumer Discretionary

    $PAYS
    Financials

    Live finance-specific insights

    See more
    • Paysign, Inc. Reports First Quarter 2025 Financial Results

      First quarter 2025 total revenues of $18.60 million, up 41.0% from first quarter 2024 First quarter 2025 net income of $2.59 million, or diluted earnings per share of $0.05, versus net income of $309 thousand, or diluted earnings per share of $0.01, for first quarter 2024 First quarter 2025 Adjusted EBITDA of $4.96 million, up 193.3% from $1.69 million a year ago, while diluted Adjusted EBITDA per share was $0.09 versus $0.03 for first quarter 20241 Total plasma center count increased by four net centers during first quarter 2025, exiting the quarter with 484 centers; revenue per plasma center decreased to $6,517 compared to $7,414 for the same period last year; year-over-year plasma

      5/8/25 4:05:00 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Paysign, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results

      For the Full-Year Full-year 2024 total revenues of $58.38 million, up 23.5% from full-year 2023 Full-year 2024 net income of $3.82 million, or diluted earnings per share of $0.07, versus net income of $6.46 million, or diluted earnings per share of $0.12 for full-year 2023 Full-year 2024 Adjusted EBITDA of $9.62 million, up 43.3% from $6.71 million a year ago, while diluted Adjusted EBITDA per share was $0.17 versus $0.12 for full-year 20231 Total plasma center count increased by 16 during 2024, exiting the year with 480 centers, contributing to a 4.6% increase in plasma revenue versus the same period last year Added 33 net patient affordability programs during 2024, exiting the y

      3/25/25 4:03:00 PM ET
      $PAYS
      Business Services
      Consumer Discretionary
    • Paysign, Inc. Reports Second Quarter 2024 Financial Results

      Second quarter 2024 total revenues of $14.33 million, up 29.8% from second quarter 2023 Second quarter 2024 net income of $697 thousand, or diluted earnings per share of $0.01, versus net loss of $104 thousand, or diluted earnings per share of $(0.00) for second quarter 2023 Second quarter 2024 Adjusted EBITDA of $2.24 million, up 95.8% from $1.14 million for second quarter 2023, while diluted Adjusted EBITDA per share was $0.04 versus $0.02 for second quarter 20231 Total plasma center count increased by eight net new centers during second quarter 2024, exiting the quarter with 477 centers, contributing to a 12.6% increase in plasma revenue versus the same period last year Adde

      7/31/24 4:02:00 PM ET
      $PAYS
      Business Services
      Consumer Discretionary